The American Heart Association has expanded its education portfolio to help clinicians translate the first-ever cardiovascular-kidney-metabolic (CKM) syndrome guideline into practice. The new resources, announced in October, range from 15-minute micro-learnings to in-depth courses and practical tools, with continuing education credit offerings varying by activity. The move matters because cardiovascular, kidney, and metabolic conditions—such as Type 2 diabetes and obesity—often overlap, making coordinated care increasingly important. By equipping healthcare professionals with accessible, evidence-based education, the Association aims to improve diagnosis and management of these interconnected conditions and ultimately reduce the burden of cardiovascular disease.
Since 2023, the American Heart Association has been a leader in advancing CKM health by convening experts across science, clinical care, and industry and developing resources to help improve diagnosis and management. "CKM syndrome challenges clinicians to look beyond a single condition and consider how cardiovascular, kidney and metabolic health influence one another," said Ambar Kulshreshtha, M.D., Ph.D., a family practice physician who is a member of the Association's CKM health Initiative and a professor of family and preventive medicine at Emory School of Medicine in Atlanta, Georgia. "These educational resources support a range of learning styles and busy schedules, giving care team members practical ways to build knowledge, stay current with the latest evidence and apply recommendations."
The Association's CKM education can be found on the CKM Health for Professionals site, which is designed to help physicians, nurses, pharmacists, and other members of the healthcare team confidently apply the latest CKM science in practice. The offerings include Micro-Learnings (15 minutes or less), short videos and activities that allow healthcare professionals to build actionable CKM knowledge and skills quickly. Clinicians can refresh their knowledge on measuring waist circumference or hear highlights from the 2026 Cardiovascular-Kidney-Metabolic Syndrome Guideline. Other topics include the PREVENT equations, a framework for weight management conversations, and bridging gaps in CKM care.
For deeper dives, the Association offers podcasts, videos on demand, and a virtual summit. The CKM Syndrome Guideline Unpacked: A Unified Approach for Interdisciplinary Prevention & Care features insights from the guideline writing committee. Additional offerings address cardiovascular risk assessment, chronic kidney disease screening, GLP-1 receptor agonists, and managing patients with heart failure and CKM syndrome.
Practical tools are also available, including a QuickStart guide for the American Heart Association Predicting Risk of cardiovascular disease EVENTsTM (PREVENT) Online Calculator, which estimates 10- and 30-year cardiovascular disease risk by integrating cardiovascular, kidney, and metabolic health measures. The Guidelines-on-the-Go app puts the latest science and clinical recommendations at your fingertips, and the CKM Care Clinical QuickStart Guide offers a concise, step-by-step approach to screening, risk stratification, staging, and management.
Several of these educational experiences are offered by the American Heart Association's Cardiovascular-Kidney-Metabolic Health Initiative™, supported by founding sponsors Novo Nordisk and Boehringer Ingelheim, supporting sponsors Novartis Pharmaceuticals Corporation and Bayer, and champion sponsor DaVita. The initiative is a specific effort to raise awareness of the connections between CKM syndrome conditions, improve diagnosis rates, and help clinicians and patients better manage their risk for cardiovascular disease.
For regular updates on new science and learning opportunities, clinicians can follow American Heart Association Science on X @HeartNews. More information is available at heart.org and stroke.org. The original release can be viewed on www.newmediawire.com.


